ICD-10-CM Billable Code

F17.299

Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F17.299 refers to a diagnosis involving nicotine dependence on tobacco products not specified as cigarettes, along with unspecified disorders caused by nicotine. Nicotine dependence is a chronic condition characterized by a strong craving for nicotine, leading to continued tobacco use despite health risks. This diagnosis highlights the complex impact of nicotine on the body and mind, often including a range of health issues caused by its addictive properties. Recognizing and understanding this condition is essential for healthcare providers and affected individuals to manage and treat the addiction effectively.

Causes & Symptoms

Clinical Causes: Regular use of various tobacco products such as cigars, pipe tobacco, chewing tobacco, or snuff Genetic predisposition influencing addictive behaviors Environmental factors including peer pressure, family habits, and advertising Psychological factors like stress, anxiety, or depression that may lead to tobacco use as a coping mechanism Previous exposure to nicotine or tobacco products at a young age

Key Symptoms: Intense cravings for tobacco products Difficulty abstaining from tobacco use despite health concerns Withdrawal symptoms such as irritability, anxiety, difficulty concentrating, increased appetite, or sleep disturbances when not using tobacco Persistent desire or unsuccessful efforts to cut down or control tobacco use spending a significant amount of time in activities associated with obtaining or using tobacco Continued use despite awareness of health problems caused by tobacco Eating or drinking habits associated with tobacco use

Diagnostic & Treatment

Diagnosis Path: Diagnosis of nicotine dependence with unspecified nicotine-induced disorders involves clinical assessment based on patient history and behaviors. Healthcare providers primarily use criteria outlined in diagnostic manuals to determine the presence of dependence, which includes aspects like tolerance, withdrawal, control over use, and continued use despite negative consequences. Additional assessments may involve blood or urine tests to measure nicotine or its metabolites, though diagnosis largely relies on patient-reported behaviors and symptoms.

Treatment Protocols: Managing nicotine dependence typically includes a combination of behavioral therapies and pharmacological treatments tailored to individual needs. Common strategies include: - **Behavioral counseling** to develop coping strategies and modify patterns of tobacco use - **Nicotine Replacement Therapy (NRT)** such as patches, gum, lozenges, or inhalers to reduce withdrawal symptoms - **Medications** like bupropion or varenicline, which can help diminish cravings and withdrawal effects - **Support groups and educational programs** to provide encouragement and information - **Lifestyle modifications** to reduce triggers and establish healthier habits Effective treatment often involves a comprehensive approach, including ongoing support and monitoring to promote sustained tobacco abstinence.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F17.299 a billable ICD-10 code?
Yes, F17.299 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F17.299?
Clinical documentation must specify the nature of Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders and any associated comorbidities for accurate reporting.

Cite this Clinical Reference